A House of Representatives hearing will take place this week about FDA funding. Included in the hearing will be the issue of the current shortages of some life-saving medicines. The number of drugs in short supply in 2011 was 220 which was a substantial increase from only 56 drugs in 2006. The Senate is also trying to help out the issue of drug shortages as Representatives John Carney (D-Delaware) and Larry Bucshon (R-Indiana) have proposed a third drug shortage bill. The bill would require that the Drug Enforcement Administration (DEA) raise its quota for certain controlled substances if there are needs for drugs that are in short supply. To learn more about the plan to fix the drug shortage, click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.